Intensity Therapeutics Inc (INTS) Annual Balance Sheets

Annual · GAAP · USD millions
Access INTS quarterly Balance Sheets →
Examining balance sheet movements between Intensity Therapeutics Inc and reveals how Dec 31 2025 adjusts its asset composition and liability profile.
Annual Report, GAAP in USD millions
ITEM
(Dec 31 2025)
(Dec 31 2024) (Dec 31 2022)
Assets
Cash & cash equivalent11.92
Cash & Short-term Investments11.00
Prepaid Expense And Other Assets Current0.79
Total Current Assets12.71
Tax Assets, Noncurrent0.00
Other Assets, Noncurrent1.39
Operating Lease Right Of Use Asset0.10
Total Assets14.10
Liabilities
Accounts Payable, Current AC0.58
Accrued Liabilities, Current AC1.53
Short-term Debt0.00
Other Liabilities, Current0.03
Total Current Liabilities2.15
Long-term Debt Convertible0.00
Total Long-term Debt0.00
Accrued Income Taxes, Noncurrent0.00
Other liabilities, Noncurrent0.08
OperatingLeaseLiabilityNoncurrent0.08
Operating Lease Liability Current0.03
Total Liabilities2.23
Stockholders' Equity
Additional Paid In Capital Common Stock90.27
Retained Earnings / Accumulated Deficit-78.39
Common Stockholder's Equity11.88
Non-controlling interests & other0.00
Total Stockholder's Equity11.88
Liabilities & Stockholder's Equity14.10
4 historic quarters locked

Sign in to unlock the full Intensity Therapeutics Inc balance sheet history.

About Intensity Therapeutics Inc Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001567264-26-000024

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API License